GeneWorx Capital
The Growth Factor for Emerging Life Science Companies
Sectors
Pharma
- Drug Discovery and Pre-Clinical NME’s
- Antibody and Peptide Drug Conjugates
- Tumor-Targeting Platforms
- Nanoparticle Delivery Platforms
- High Throughput Screening
- Bioinformatics Tools and Platforms
- Continuous Manufacturing
- Drug Discovery and Clinical Trial Software
- Cancer Immunotherapies
- Microbiome
Biotech
- Point-of-Care Diagnostics
- Boron Neutron Capture Therapy
- Molecular Diagnostics
- Microfluidics
- Lab Automation and Robotics
- Genomics Databases and Bioinformatics
- Enzymes, Proteins and Genomic Libraries
- Medical Devices
- Medical Imaging Technology
- Industrial Biotechnology
Synthetic Biology
- Disease Therapeutics
- Nanomaterials
- Biosensors
- Biomachines and Nanorobots
- DNA Design and Synthesis
- Micro-Organism Design and Synthesis
- Renewable Chemicals
- Biofuels
- Pollution Remediation
- Synthetic Foods and Beverages
Recent GeneWorx Clients
Companies commercializing life science and medical device innovations
Medical Devices
Rapid diagnostic test platform that delivers central lab quality results at point of care in under 10 minutes
Drug Development
Peptide drug conjugate platform using CXCR4 antagonist for treating triple negative breast, acute myeloid leukemia and other difficult cancers
Medical Devices
Boron Neutron Capture Therapy (BNCT) – cancer cell selective radiotherapy using boron-10 and low-energy neutron beam that targets tumor cells without damage to surrounding tissues
Synthetic Biology
High throughput CRISPR/RNAi arrayed screening platform that enables massively parallel experimentation without the need for expensive automation
Synthetic Biology
Synbio fermentation platform for high volume manufacturing of 100% natural, non-GMO specialty flavors and fragrances
Medical Devices
Precision oncology test that identifies each patient’s most effective anticancer treatment
Bioinformatics and Software
Laboratory workflow platform for clinical trial and drug development acceleration
Vaccine Development
Universal coronavirus vaccine protects against all strains of coronavirus including COVID-19 and its possible future mutations
Drug
Development
Liposomal Nanoparticle Technology Platform (LNPT) for oncology, immunology, and pain management drugs delivered orally, parenterally, and topically
GeneWorx helped these companies raise capital, out-license with upfront/milestone/royalty payments,
acquire companies/technologies, recruit executives and advisors, build distribution channels, and more.